Introduction
Staphylococcus aureus is an opportunistic pathogen that causes disease in a wide range of tissues including skin, kidney, bone, lung and heart (Liu et al., 2011; Tong et al., 2015) . Each infectious niche poses unique challenges to S. aureus survival due to significant differences in nutrient bioavailability at each site. To thrive in such a wide range of environments, S. aureus harnesses key adaptive traits that permit trace metal/nutrient acquisition, maintenance of metabolic homeostasis and survival in nutritionally deficient or otherwise inhospitable conditions (Mazmanian et al., 2003; Beasley and Heinrichs, 2010; Cassat and Skaar, 2012; Hood and Skaar, 2012; Richardson et al., 2015; Grim et al., 2017; Kelliher et al., 2017) . Aside from a relatively welldeveloped understanding of trace metal acquisition, the mechanisms used by S. aureus to acquire other scarce nutrients remains comparatively understudied.
In addition to the necessity for trace metal scavenging for optimal metabolic activity and bacterial survival, S. aureus also requires the essential cofactor lipoic acid (Zorzoli et al., 2016; Grayczyk et al., 2017) . Lipoic acid, a derivative of the medium-chain fatty acid octanoic acid, is a sulfur-containing cofactor that is covalently attached to conserved lysine residues in multi-subunit enzyme complexes needed for aerobic metabolism, fatty acid biosynthesis, glycine detoxification and maintenance of redox homeostasis (Spalding and Prigge, 2010; Cronan, 2016) . Five lipoylated enzyme complexes are used in bacteria: pyruvate dehydrogenase (PDH) catalyzes the oxidative decarboxylation of pyruvate to acetyl CoA; 2-oxoglutarate dehydrogenase (OGDH) converts a-ketoglutarate to succinyl-CoA; branched-chain 2-oxoacid dehydrogenase (BCODH) degrades branched chain amino acids to make a branched chain CoA intermediate needed for fatty acid biosynthesis; acetoin dehydrogenase (AoDH) is similar to the PDH complex and also catalyzes the conversion of pyruvate to acetyl CoA; and the glycine cleavage system (Gcs) catalyzes the reversible decarboxylation of glycine (Perham, 2000; Spalding and Prigge, 2010; Cronan, 2016) . S. aureus encodes PDH, OGDH and BCODH a-ketoacid dehydrogenase complexes, as well as the Gcs, but not AoDH (Spalding and Prigge, 2010; Zorzoli et al., 2016) . The aketoacid dehydrogenases are comprised of multiple copies of three different subunits referred to as E1, E2 and E3, whereas the glycine cleavage system uses subunits referred to as P (pyridoxal phosphate-containing protein), H (hydrogen carrier protein), T (tetrahydrofolatecontaining protein) and L (lipoamide dehydrogenase) proteins (Douce et al., 2001; Kikuchi et al., 2008) . The lipoic acid cofactor is attached by an amide bond to a conserved lysine residue on E2 and H subunits and acts to channel substrates through the active sites of the enzyme complexes (Perham, 2000; Douce et al., 2001) . The necessity of lipoic acid for the activity of the a-ketoacid dehydrogenase complexes and glycine cleavage system demands a strategy to synthesize and/or salvage lipoic acid from the environment, as well as a method to attach lipoic acid to the conserved lysine within the lipoyl domains of E2 and H subunits.
A growing body of literature suggests that lipoic acid biosynthesis and salvage can have a major role in facilitating the pathogenesis of microorganisms (Spalding and Prigge, 2010) . Lipoic acid salvage in parasites such as Plasmodium falciparum, the causative agent of malaria, is crucial for survival and growth of the parasite during the blood and liver stage (Gunther et al., 2009Storm and Muller, 2012; Falkard et al., 2013; Afanador et al., 2014) . In addition, disruption of the lipoic acid biosynthesis and salvage pathway attenuates Burkholderia pseudomallei virulence in an intranasal mouse infection model (Pilatz et al., 2006) . In Pseudomonas aeruginosa, a functional lipoylated PDH enzyme complex is important for the expression of the type three secretion system (Dacheux et al., 2002) . Furthermore, disruption of dlaT, a gene encoding the E2 PDH subunit in Mycobacterium tuberculosis, results in increased susceptibility to macrophage killing and oxidative stress (Bryk et al., 2002; Bryk et al., 2013) . Listeria monocytogenes, a lipoic acid auxotroph, uses one of two lipoic acid salvage enzymes to facilitate acquisition of lipoic acid within the intracellular environment (O'Riordan et al., 2003; Keeney et al., 2007; Christensen et al., 2011a) . Overall, these examples demonstrate the range of effects that lipoic acid acquisition and lipoic aciddependent enzyme activities have on promoting pathogen survival within an infected host. Our studies with S. aureus suggest niche specific requirements for de novo biosynthesis and salvage during infection, where de novo biosynthesis is required to infect the heart and salvage is necessary for optimal infection of the kidney, highlighting the relevance of both pathways during infection (Zorzoli et al., 2016) . In addition, we have identified a novel activity for lipoyl-E2-PDH in the extracellular environment where it acts to blunt macrophage activation by toll-like receptor ligands, further expanding the relevance of protein lipoylation in the context of infection (Grayczyk et al., 2017) .
The mechanisms of lipoic acid acquisition and synthesis can vary considerably among bacteria, fungi and protozoans (Cronan, 2016) . Many of these organisms either encode a de novo biosynthesis pathway, salvage pathway, or both. Each confers a range of acquisition strategies that presumably have evolved to satisfy the unique lipoic acid requirements of that particular microorganism within its replicative niche. Most studies of lipoic acid biosynthesis and salvage in bacteria were conducted in Escherichia coli, Bacillus subtilis and L. monocytogenes (Vanden Boom et al., 1991; Morris et al., 1995; Miller et al., 2000; Jordan and Cronan, 2003; Zhao et al., 2003; Hermes and Cronan, 2009; Christensen and Cronan, 2010; Christensen et al., 2011ab; Martin et al., 2011; Cronan, 2016) . These studies highlight the diversity of lipoic acid biosynthesis and salvage strategies between bacterial species. Recently, our lab used a genetic approach to define the lipoic acid acquisition pathways of S. aureus (Zorzoli et al., 2016) . This work determined that S. aureus has a complex lipoic acid biosynthesis and salvage pathway that bears similarities to that of B. subtilis and L. monocytogenes combined. S. aureus encodes the three characteristic enzymes needed for de novo biosynthesis in B. subtilis, LipM, LipA and LipL, as well as iron sulfur cluster biogenesis proteins, SufCDSUB and SufT, needed for incorporation of sulfur into the lipoic acid molecule (Christensen and Cronan, 2010; Christensen et al., 2011b; Martin et al., 2011; Mashruwala et al., 2016; Roberts et al., 2017) . However, it also encodes two lipoic acid ligases, LplA1 and LplA2, needed for salvage during infection and two H proteins, GcvH and GcvH-Like (GcvH-L), which we suspect may be used as a source of lipoyl protein for subsequent transfer to E2 subunits by an amidotransferase (Christensen et al., 2011a; Zorzoli et al., 2016; Cao et al., 2018) .
As with B. subtilis, lipoic acid synthesis in S. aureus begins with transfer of octanoic acid, a medium chain fatty acid, from its acyl carrier protein (ACP) to GcvH by the octanoyl transferase, LipM (Christensen and Cronan, 2010; Zorzoli et al., 2016) . The lipoyl synthetase, LipA, then converts the octanoyl moiety to lipoic acid, followed by transfer of the lipoyl group from GcvH to the E2 subunits of PDH, BCODH and OGDH by LipL (Christensen et al., 2011b; Martin et al., 2011; Zorzoli et al., 2016) . S. aureus contains two additional enzymes that have activities associated with lipoic acid salvage from the host environment, LplA1 and LplA2 (Zorzoli et al., 2016) . This is reminiscent of L. monocytogenes, which also encodes two lipoic acid ligases, but unlike S. aureus, has no de novo biosynthesis enzymes (Keeney et al., 2007; Christensen et al., 2011a) . In L. monocytogenes, LplA1 is integral for lipoic acid acquisition in vitro and in vivo, whereas LplA2 only facilitates acquisition in vitro (Keeney et al., 2007) . In a similar vein, S. aureus LplA1, but not LplA2, was found to be crucial for the salvage of lipoic acid in vitro (Zorzoli et al., 2016) . However, in vivo studies indicate that either LplA1 or LplA2 is sufficient to promote kidney infection during murine systemic infection. Because the LplA2 ligase does not have a discernable function in vitro -unless bacteria are cultured in the presence of fetal bovine serum (FBS) -its exact mode of action in lipoic acid salvage is unknown (Zorzoli et al., 2016) . Furthermore, LplA2 is encoded in an operon containing an ADP-ribosyltransferase, macrodomain protein, luciferase-like monooxygenase and the H subunit-like protein GcvH-L (Rack et al., 2015; Zorzoli et al., 2016) . This operon is postulated to participate in lipoic acid-dependent maintenance of redox homeostasis, which suggests that LplA2 may have roles that extend beyond lipoic acid salvage (Rack et al., 2015) . Nonetheless, the presence of a potential alternative H protein encoded within this operon may indicate an unusual layer of complexity should lipoyl GcvH-L indeed act as a substrate in lipoic acid transfer (Cao et al., 2018) . Based on this information, we hypothesized that LplA1 and LplA2 in S. aureus use alternative lipoylated substrates and/or the enzymes have different lipoylation targets, thereby providing S. aureus with an increased degree of flexibility in its mechanisms of lipoic acid acquisition in lipoic acidlimiting environments.
In this study, we used a biochemical approach to interrogate the activity of both LplA1 and LplA2 of S. aureus. We found that LplA1 attaches lipoic acid primarily to the H subunit, GcvH and the H subunit-like protein, GcvH-L, whereas LplA2 attaches lipoic acid to E2 subunits, as well as operon-linked GcvH-L. Each ligase functions independently, with limited overlap in protein targets. Furthermore, both ligases have the capacity to use octanoic acid as a substrate for attachment to GcvH and GcvH-L. Neither enzyme uses lipoyl tripeptides as a substrate unless co-incubated with crude lysates of S. aureus, which harbors lipoamidase activity. Furthermore, GcvH and GcvH-L both provide a source of lipoyl protein for subsequent transfer to E2 subunits, despite a postulated role for GcvH-L in orchestrating resistance to host-derived redox stress (Rack et al., 2015) . Taken together, these studies highlight the importance of the divergent functions of LplA1 and LplA2, as well as the contributions of both GcvH and GcvH-L to protein lipoylation and likely explains why S. aureus thrives so well when faced with low levels of free lipoic acid during host infection.
Results

S. aureus LplA1 promotes lipoic acid salvage and stimulates bacterial replication in broth culture
Our genetic analyses of lipoic acid biosynthesis and salvage in S. aureus have led to a model whereby the enzymes LipM, LipA and LipL comprise a functional de novo lipoic acid biosynthesis pathway that acts in vitro and within certain tissues in vivo (Fig. 1A) (Zorzoli et al., 2016) . In addition, S. aureus produces two lipoic acid salvage enzymes, LplA1 and LplA2, implying potential for flexibility in lipoic acid salvage. However, biochemical studies to date suggest the activity of LplA2 is limited to lipoylation of GcvH-L (Fig. 1A) (Rack et al., 2015) . In contrast, our genetic analyses indicate that LplA1 and LplA2 are both sufficient to promote survival of a lipoic acid auxotroph during infection, implying some degree of functional overlap between LplA1 and LplA2, at least in the host environment (Zorzoli et al., 2016) . To begin to interrogate the ligase activities of LplA1 and LplA2, we conducted a series of growth curves using S. aureus strains harboring deletions of lipA and one or both lipoic acid ligases, followed by complementation with lplA1 or lplA2 driven by a constitutive promoter. When inoculated into medium lacking free lipoic acid (RPMI) or supplemented with the de novo biosynthesis precursor octanoic acid (OA), only the wild type strain was able to replicate ( Fig. 1B and C) . In contrast, supplementation of the medium with lipoic acid restored wild type growth characteristics to DlipA DlplA2 and DlipA DlplA1 DlplA2 1 lplA1 strains, while DlipA DlplA1 and DlipA DlplA1 DlplA2 1 lplA2 strains were unable to replicate (Fig. 1D ). These data support our prior studies and suggest that LplA1, but not LplA2 scavenges free lipoic acid to support bacterial replication (Zorzoli et al., 2016) .
Both LplA1 and LplA2 are sufficient to promote lipoylation of E2 and H subunits
The fact that LplA2 is unable to support replication of lipoic acid auxotrophs in the presence of lipoic acid was unusual given our observation that LplA2 is sufficient to promote kidney infection by DlplA1 DlplA2 and DlipA DlplA1 DlplA2 1 lplA2 strains (Zorzoli et al., 2016) . Furthermore, a DlipA DlplA1 DlplA2 1 lplA2 strain constitutively expresses high levels of LplA2 in broth culture as determined by immunoblot with polyclonal rabbit aLplA2 antibody ( Fig. 2A) . Thus, although restoration of growth was not observed, we reasoned that we might still detect ligase activity for LplA2 by monitoring protein lipoylation. To this end, we tested whether or not the DlipA DlplA1 DlplA2 1 lplA2 strain is capable of lipoylating E2 and H proteins despite the inability of LplA2 to restore growth in broth culture. WT, DlipA DlplA1 DlplA2, DlipA DlplA1 DlplA2 1 lplA1, DlipA DlplA1 DlplA2 1 lplA2 strains were grown in medium containing the branched chain fatty acid precursors isobutyric acid, isovaleric acid and 2-methylbutyric acid (BCFA), to bypass the requirement of lipoic acid for growth (Martin et al., 2009;  A. Immunoblot with a-LplA2 antibody of whole cell lysates derived from the indicated strains grown in RPMI supplemented with branched chain carboxylic acids (10 mM isobutyric acid, 9 mM 2-methylbutyric acid, 9 mM isovaleric acid and 10 mM sodium acetate -BCFA) to bypass the requirement of lipoic acid for replication. B. Immunoblot with a-lipoic acid antibody of whole cell lysates derived from the indicated strains grown in the same medium as (A) and supplemented with 5 lM lipoic acid (LA) or 150 lM octanoic acid (OA). The positions of the four lipoyl proteins in S. aureus (E2-PDH, E2-OGDH, E2-BCODH and GcvH) are indicated. Strain designations are as follows: wildtype (WT), DlipA DlplA1 DlplA2 (DA DA1 DA2), DlipA DlplA1 DlplA2 1 lplA1 (DA DA1 DA2 1 A1) and DlipA DlplA1 DlplA2 1 lplA2 (DA DA1 DA2 1 A2). Martin et al., 2011) . The medium was supplemented with either lipoic acid or octanoic acid, followed by immunoblot of whole cell lysates to ascertain LplA1 and LplA2-dependent protein lipoylation. Contrary to its inability to grow in the presence of free lipoic acid, the DlipA DlplA1 DlplA2 1 lplA2 strain resembled a DlipA DlplA1 DlplA2 1 lplA1 strain in its lipoylation of E2-PDH, E2-OGDH and GcvH with modest reductions in the lipoylation on E2-BCODH ( Fig. 2B and Supporting Information Fig. S1 ). Lipoylation of these same subunits when grown in BCFA medium or BCFA supplemented with octanoic acid was only observed for the wild type strain ( Fig. 2B and Supporting Information Fig. S1 ). In summary, LplA1 and LplA2-dependent salvage of lipoic acid occurs in broth culture.
Interrogating the functional activities of LplA1 and LplA2
Thus far, our data indicate that LplA1 and LplA2 behave as lipoic acid ligases. However, their exact biochemical function and protein targets remain unclear. In E. coli, the lipoic acid ligase is a promiscuous enzyme and attaches lipoic acid or octanoic acid to most H proteins as well as E2 subunits from a variety of species (Morris et al., 1994; Green et al., 1995) . In contrast, lipoic acid attachment in B. subtilis and L. monocytogenes occurs on the H subunit of the glycine cleavage system followed by transfer to E2 subunits by the amidotransferase LipL (Christensen et al., 2011a (Christensen et al., , 2011b . These enzymes do not appreciably target E2 subunits in vitro (Christensen et al., 2011a (Christensen et al., , 2011b . The diversity of functions in the ligase family of enzymes argues that the biochemical functions, protein targets, or substrates could vary between LplA1 and LplA2 (Cronan, 2016) . Therefore, to interrogate the activities of the ligases in greater detail, we purified recombinant S. aureus LplA1 and LplA2 from E. coli for use in in vitro lipoylation assays with purified S. aureus E2-PDH, E2-OGDH, E2-BCODH, GcvH and GcvH-L (Fig. 3A) .
LplA1 and LplA2 targeting of GcvH and GcvH-L S. aureus contains a canonical GcvH protein important for glycine cleavage, but also encodes a GcvH-Like protein (GcvH-L), with 29% amino acid identity (54% similarity) to GcvH. GcvH-L is encoded in a putative operon with the lplA2 gene -the last gene in the operon (Zorzoli et al., 2016) . Our genetic evidence supports a model where, in addition to its role in glycine cleavage, GcvH acts as a major conduit for transfer of lipoic acid to E2 subunits by the amidotransferase LipL (Zorzoli et al., 2016) . GcvH-L, like LplA2, does not appear to be expressed in broth culture, precluding direct assessment of its activity (Nobre and Saraiva, 2013; Rack et al., 2015; Zorzoli et al., 2016) . Based on their proposed assignment as H proteins, we reasoned that both GcvH of the glycine cleavage system and GcvH-L are targets for lipoylation by one or both S. aureus ligases. Support from this notion comes from Rack et al, who demonstrated that a 1:1 to 1:2 molar ratio of S. aureus LplA1 or LplA2 and GcvH-L is sufficient to promote lipoylation (Rack et al., 2015) . To begin to decipher the A. GelCode Blue stained SDS-PAGE gels containing 2 lg of the salvage enzymes, LplA1 and LplA2, and lipoyl domain containing subunits E2-PDH, E2-OGDH, E2-BCODH, GcvH and GcvH-L. B,C. LplA1 and LplA2 attachment of (B) lipoic acid (2.4 mM) and (C) octanoic acid (2.4 mM) to GcvH and GcvH-L. Lipoylation was assessed by conducting an immunoblot (IB) with rabbit a-lipoic acid antibody. Parallel 12% SDS PAGE gels were stained with GelCode Blue (CB). Octanoylation was visualized as a shift in apparent molecular weight after resolving proteins on a 12% SDS-PAGE gel and staining with GelCode Blue (CB).
biochemical mechanisms of lipoic acid salvage in S. aureus, we first tested the ability of LplA1 and LplA2 to attach free lipoic acid to one of these two H proteins. Lipoylation assays conducted with LplA1 or LplA2 and GcvH (molar ratio of enzyme to substrate 1:20) with free lipoic acid showed complete lipoylation of GcvH by LplA1, as evidenced by immunoblot with a-lipoic acid antibody and a shift in apparent molecular weight presumably due to a loss of positive charge at the conserved lysine of the lipoyl domain after attachment ( (Posner et al., 2009; Martin et al., 2011) . In contrast, no lipoylation was detected for reactions containing LplA2 and GcvH. When LplA1 and LplA2 were used in lipoylation reactions with GcvH-L, lipoylation by immunoblot and shifts in apparent molecular weight were observed regardless of the ligase used ( Fig. 3B and Supporting Information Fig. S2A , right) (Rack et al., 2015) . When octanoic acid was used in place of lipoic acid, we found that LplA1 could target both GcvH and GcvH-L for octanoic acid attachment, whereas LplA2 only targeted GcvH-L ( Fig. 3C and Supporting Information Fig. S2B ). Taken together, these data indicate that LplA1 is indiscriminate in its ability to attach lipoic acid and octanoic acid to S. aureus H proteins, whereas LplA2 attaches lipoic acid and octanoic acid to GcvH-L.
LplA1 and LplA2 targeting of E2 proteins
Our prior genetic data and H protein lipoylation studies presented here suggest that S. aureus LplA1 and LplA2 functions diverge in such a way that each has different targets for lipoyl attachment (Zorzoli et al., 2016) . A scenario such as this would increase the likelihood of sufficient lipoylation in the absence of de novo biosynthesis, allow for fine-tuning of protein lipoylation in cases where requirements for exogenous lipoic acid are high, or facilitate lipoylation of a particular enzyme complex over another. To test the range of E2 protein targets of LplA1 and LplA2, we conducted lipoic acid attachment assays with purified lipoyl domain-containing E2 proteins of S.
aureus -E2-PDH, E2-OGDH and E2-BCODH. In a reaction containing E2-PDH and LplA2, a prominent lipoyl protein band was detected after immunoblot with a-lipoic acid antibody ( Fig. 4A and Supporting Information Fig. S3A ). Modest, but detectable lipoylation over that of the control reaction containing only E2-PDH and lipoic acid was observed in reactions with LplA1. In reactions containing E2-OGDH, lipoylation was seen in the presence of LplA1 and LplA2 although LplA2-dependent attachment was more robust than that caused by LplA1 ( Fig. 4B and Supporting Information Fig. S3B ). In contrast, lipoic acid attachment to E2-BCODH was only observed in the presence of LplA2, but not LplA1 ( Fig. 4C and Supporting Information Fig.  S3C ). Although a faint band was observed in lanes from reactions with LplA1, this band was also present in control wells containing only E2-BCODH and lipoic acid (Fig. 4C ). These data suggest that LplA1-mediated lipoic acid attachment to E2 subunits is limited, whereas LplA2 is promiscuous and targets all three E2 subunits for lipoic acid attachment.
Use of lipoyl peptides as a source of lipoic acid requires lipoamidase activity and LplA1 or LplA2
Thus far, our data indicate that the lipoic acid ligases of S. aureus are capable of attaching free lipoic acid to E2 and H protein subunits with different efficiencies. However, free lipoic acid is limiting within the host environment and is likely to be present attached to lysine residues within conserved lipoyl domains via an amide bond. Previous studies with L. monocytogenes suggest that lipoamide can be used as a source of lipoic acid to stimulate growth, by virtue of the activity of an L. monocytogenes-encoded lipoamidase (Christensen et al., 2011a) . We wondered whether or not peptide-bound lipoic acid might facilitate growth of S. aureus lipoic acid auxotrophs. We first tested if supplementation of RPMI medium with porcine PDH was sufficient to stimulate growth of gene deletion mutants lacking one or both ligases in a DlipA mutant background. Addition of PDH was unable to promote growth of any mutant strain tested (Fig. 5A ). In contrast, when PDH was first coincubated with proteinase K agarose beads prior to supplementation, the DlipA DlplA2 and DlipA DlplA1 DlplA2 1 lplA1 strains grew identically to the WT strain (Fig. 5B ). Because commercial porcine PDH is unlikely to be uniformly pure, we synthesized a series of tripeptides [Asp-Lys-Ala (DKA), Asp-Lys Lipoyl -Ala (DK L A), AspLys-Thr (DKT) and Asp-Lys Lipoyl -Thr (DK L T)] that resemble the minimum peptides generated by digestion of porcine PDH with proteinase K (Keeney et al., 2007) . These tripeptides are sufficient to stimulate the growth of L. monocytogenes in the absence of free lipoic acid (Keeney et al., 2007; Christensen et al., 2011a) . We monitored the growth of the indicated S. aureus strains after supplementation with DKA, DK L A, DKT and DK L T into RPMI medium. Growth was restored for the DlipA DlplA2 and DlipA DlplA1 DlplA2 1 lplA1 strains, but only when the peptide containing the lipoyl moiety was present ( Fig. 5C-F) . Consistent with prior observations with lipoic acid, lipoyl peptides were unable to promote growth of DlipA DlplA1 and DlipA DlplA1 DlplA2 1 lplA2 strains (Fig. 5C-F) .
Stimulation of growth after supplementation with lipoyl peptides suggests that S. aureus is capable of acquiring lipoic acid from its lysine-bound state. The ability to do so would either require intrinsic amidotransferase activity within LplA1 or LplA2, or the presence of an enzyme with lipoamidase activity. To test whether or not LplA1 or LplA2 harbors amidotransferase activity, we conducted biochemical assays with recombinant LplA1 or LplA2 with GcvH, GcvH-L, E2-PDH, E2-OGDH, E2-BCODH and DK L A. Neither LplA1 
GcvH-L is sufficient to restore growth to a lipoic acid auxotroph in the absence of free lipoic acid LplA1 and LplA2 both attach lipoic acid to GcvH-L, while LplA1 only lipoylates GcvH. Although GcvH-L has been implicated in promoting resistance to redox stress during infection, its classification as a lipoyl domain H protein and recent evidence for evolutionary maintenance of H proteins as lipoyl reservoirs suggests that it may also promote lipoic acid biosynthesis and salvage (Rack et al., 2015; Cao et al., 2018) . In Gram-positive Firmicutes, the H subunit of the glycine cleavage system is a critical conduit for the transfer of lipoic acid to E2 subunits, an activity that is mediated by the LipL amidotransferase (Christensen et al., 2011a (Christensen et al., , 2011b Martin et al., 2011) . A DgcvH mutant is unable to replicate in the absence of free lipoic acid due to an inability to shuttle lipoic acid from GcvH to E2 proteins (Christensen et al., 2011b; Zorzoli et al., 2016) . To test whether or not GcvH-L is sufficient to restore growth to a DgcvH mutant in the absence of free lipoic acid -and hence restore lipoyl transfer to E2 proteins -we generated DgcvH 1 gcvH, DgcvH 1 gcvH-L and DgcvH 1 gcvH-L* [containing a single mutation K56A to remove the conserved lysine of the lipoyl domain (Rack et al., 2015) ] strains, wherein the expression of gcvH, gcvH-L and gcvH-L* is driven by the constitutive P HELP promoter. We subsequently monitored growth on solidified RPMI medium, growth in RPMI liquid culture and lipoylation of E2 and H proteins in cell lysates. Expression of either GcvH or GcvH-L permitted growth on solid agar plates lacking lipoic acid, while expression of GcvH-L* displayed poor growth (Fig.  7A) . Furthermore, DgcvH 1 gcvH and DgcvH 1 gcvH-L strains grew to similar final optical densities in broth culture, although the DgcvH 1 gcvH-L strain had a slightly reduced growth rate compared to WT and DgcvH 1 gcvH strains (Fig.  7B) . In contrast, the DgcvH 1 gcvH-L* strain grew poorly and resembled the DgcvH mutant. Supplementation of lipoic acid into the culture medium restored WT growth characteristics to all strains due to limited lipoic acid attachment to E2-OGDH and subsequent transfer to other E2 subunits as seen in our prior studies [Fig. 7C and (Zorzoli et al., 2016) ]. Immunoblots of whole cell lysates derived from the DgcvH 1 gcvH strain in BCFA medium lacking lipoic acid yielded prominent bands corresponding to lipoylation of all E2 proteins (Fig. 7D, left and Supporting Information Fig. S6 ). Similarly, lysates derived from the DgcvH 1 gcvH-L strain contained a dominant lipoyl E2-PDH band with detectable, albeit reduced, levels of lipoylation on E2-OGDH and E2-BCODH (Fig. 7D, left) . Lysates derived from the DgcvH 1 gcvH-L* strain had low levels of lipoylation on E2 subunits that were similar to the background levels seen in a DgcvH mutant (Fig. 7D, left) . Lipoylation of all E2 subunits was observed when the BCFA medium was supplemented with exogenous lipoic acid (Fig. 7D, right and Supporting Information Fig. S6) . A band corresponding to lipoyl GcvH-L was not detected in any condition after immunoblot (Fig. 7D) . Identical results were obtained when experiments were repeated with a DgcvH DgcvH-L double mutant and DgcvH DgcvH-L 1 gcvH or DgcvH DgcvH-L 1 gcvH-L strains (Supporting Information Fig. S7 ) Together, these data indicate that both GcvH and GcvH-L are sufficient to promote lipoyl transfer in S. aureus with important implications for both de novo biosynthesis and salvage of lipoic acid since H proteins are required for de novo biosynthesis, but are also direct targets of LplA1 and LplA2 (Fig. 3) .
Discussion
Microbial pathogens depend on a wide range of adaptive traits to promote their survival in nutrient-limited conditions. Trace nutrient acquisition pathways constitute a key bacterial survival strategy during infection. In this study, we used a biochemical approach to dissect the functional overlap between two lipoic acid ligases and two H proteins of S. aureus as it relates to flexibility in lipoic acid acquisition. Our findings indicate that LplA1 and LplA2 indeed harbor canonical lipoic acid ligase activity, but differ in their protein targets as outlined in Fig. 8 . LplA1 primarily lipoylates H proteins, whereas LplA2 has the capacity to target a wider range of proteins including the three E2 subunits of PDH, OGDH and BCODH (Fig. 8A and B) . Neither of these ligases harbors secondary amidotransferase activity that permits the use of substrates other than free lipoic acid. However, S. aureus appears to make a soluble lipoamidase that allows use of peptide-bound lipoic acid by these ligases (Fig. 8A and B) . Furthermore, the ability to produce two H proteins -one that is expressed in culture and one that is posited to be upregulated in vivo or during periods of redox stress -provides an additional source of protein bound lipoic acid for transfer to E2 subunits. Together, these findings expand our understanding of lipoic acid salvage in S. aureus, and suggest an adaptive strategy that makes this pathogen extremely adept at lipoic acid acquisition.
The lipoic acid ligase of B. subtilis, LplJ, targets GcvH but not other E2 subunits, while LplA of E. coli is indiscriminate in its recognition of lipoyl domain lysines (Morris et al., 1994; Green et al., 1995; Christensen et al., 2011a Christensen et al., , 2011b . This function for LplA in E. coli is logical because prior lipoyl attachment to GcvH and subsequent transfer to E2 subunits is not required for synthesis of lipoic acid (Cronan, 2016) . In B. subtilis and L. monocytogenes, conversely, GcvH serves as an important conduit for lipoic acid transfer to E2 subunits due to the amidotransferase activity of LipL (Christensen et al., 2011a (Christensen et al., , 2011b Martin et al., 2011) . Direct lipoylation of H subunits in this scenario allows GcvH to serve as a source of lipoic acid for the bacterial cell. However, herein lies a potential bottleneck for these Gram positive species during periods of lipoic acid starvation; salvage and transfer to E2 subunits depends on passing through a GcvH intermediate, rather than direct lipoylation of the target E2 protein. In S. aureus, this limitation is eliminated by LplA2, which lipoylates all E2 subunits without the requirement of first passing through GcvH. However, S. aureus still maintains the LplA1 ligase, which behaves similarly to LplJ of B. subtilis and incidentally has greater amino acid sequence identity (57% compared to 39% for LplA2). The presence of two ligases with different lipoyl targets likely confers a level of added flexibility that may allow S. aureus to overcome severe limitations in bioavailable lipoic acid by directing trace amounts of the cofactor to the most critical complexes. A similar scenario may be true in L. monocytogenes, which also encodes two lipoic acid ligases, though technical difficulties in the purification of LplA2 have prevented an in-depth assessment of its biochemical activity (Christensen et al., 2011a ). An added layer of complexity in our understanding of how LplA1 and LplA2 promote lipoic acid salvage exists in the varied gene expression of the two enzymes. lplA1 is expressed both in vitro and in vivo as evidenced by: (i) the ability of a DlipA DlplA2 mutant to grow in the presence of exogenous lipoic acid in broth culture; and (ii) the fact that DlplA2 and DlipA DlplA1 DlplA2 1 lplA1 strains infect the kidneys of mice at similar levels to WT S. aureus, while DlplA1 DlplA2 and DlipA DlplA1 DlplA2 strains are markedly attenuated (Zorzoli et al., 2016) . This is not true for a DlipA DlplA1 strain, which is defective for growth and lipoylation in broth culture even in the presence of free lipoic acid -unless cultured in the presence of FBS (Zorzoli et al., 2016) . When lplA2 expression is driven by a constitutive promoter, lipoylation in the presence of exogenous lipoic acid is observed, although the levels of lipoylation on the E2 subunit of BCODH appear to be slightly lower when compared to complementation with lplA1 (Fig. 2) . Together, these observations strongly suggest that lplA2 is not normally expressed under standard growth conditions. In contrast, a DlplA1 mutant is fully virulent in vivo, while a DlplA1 DlplA2 mutant is significantly attenuated, indicating that lplA2 is expressed and sufficient to promote salvage in vivo (Zorzoli et al., 2016) . These prior observations, coupled with our new understanding of LplA1 and LplA2 targeting, suggest that variations in both gene regulation and lipoyl protein targeting are likely to greatly expand the breadth and efficiency of lipoic acid attachment in appropriate environmental conditions. Identification of an in vitro growth condition that leads to high expression of the operon containing lplA2 has yet to be uncovered despite prior suggestion that redox stress is an inducing signal (Nobre and Saraiva, 2013) . Although limited LplA2 activity is observed in the presence of FBS, this growth condition may eventually prove useful in the characterization of the gene regulatory programs of the lplA2 operon. Current work in the laboratory aims to decipher how gene regulation and the newly identified divergent activities of LplA1 and LplA2 interface with one another to promote diversification in lipoic acid acquisition.
In this study, we determined that S. aureus harbors lipoamidase activity and permits the salvage of lysinebound lipoic acid. An acquisition strategy such as this is likely imperative to an infectious microbe such as S. aureus, which can reside in host environments that have negligible free lipoic acid levels (Akiba et al., 1998; Zorzoli et al., 2016) , but instead contain significant amounts of the cofactor covalently attached to enzyme complex subunits. Enterococcus faecalis is the only bacterium with a fully characterized lipoamidase that is required for removal of lipoic acid from covalently attached lysines (Jiang and Cronan, 2005; Spalding and Prigge, 2009 ). BLAST of this sequence for similar proteins in S. aureus yielded no hits. Interestingly, Cristea and colleagues have determined that sirtuins of mammalian cells and bacteria can harbor lipoamidase activities that allow them to fine-tune the activity of major metabolic enzyme complexes (Mathias et al., 2014; Mathias et al., 2016; Rowland et al., 2017) . It stands to reason that such a sirtuin might also exist in S. aureus. In a recent study, the E. coli sirtuin, CobB, a previously characterized A,B. de novo biosynthesis of lipoic acid occurs via an octanoic acid precursor attached to acyl carrier protein (ACP). The octanoyl group is transferred to the H subunit of GcvH by the octanoyl transferase LipM. The octanoyl moiety is converted to lipoic acid by LipA and transferred to the lipoyl domains of E2-PDH, E2-OGDH, or E2-BCODH by the amidotransferase LipL. (A) LplA1 scavenges free lipoic acid and primarily attaches the cofactor to the H subunits of GcvH and GcvH-L followed by transfer to E2 subunits by LipL. (B) LplA2 also scavenges free lipoic acid, but instead attaches the cofactor to the H subunit of GcvH-L as well as the E2 subunits of PDH, OGDH and BCODH. The activity of both LplA1 and LplA2 requires free lipoic acid. However, S. aureus harbors lipoamidase (Lpd) activity that can hydrolyze the amide bond of lipoamide, providing an additional source of free lipoic acid for use by these ligases.
deacetylase, was shown to have lipoamidase activity that can regulate the function of PDH and OGDH (Rowland et al., 2017) . SrtN, the sirtuin homolog in B. subtilis also acts as a lipoamidase (Rowland et al., 2017) . A homolog of this sirtuin exists in S. aureus (SAUSA300_2157), but deletion of this gene has no effect on the ability of a S. aureus DlipA strain to grow in the presence of DK L A, suggesting that another, or more than one, lipoamidase exists to carry out this activity (Teoh, unpublished) . One unusual outcome of this study was the observation that expression of lplA2 via a constitutive promoter restored lipoylation to lipoic acid auxotrophs in the presence of free lipoic acid, but was insufficient to restore bacterial growth in the presence of free lipoic acid. A similar phenotype is observed in yeast where supplementation of the growth medium with free lipoic acid does not restore aerobic growth to a LIP5 (LipA homolog) mutant, but is sufficient to promote lipoylation of target proteins (Sulo and Martin, 1993; Hermes and Cronan, 2013) . At present, we suggest two possible explanations for this outcome. First, the observation that lipoylation of E2-BCODH is reduced in broth culture after complementation with lplA2 compared to WT suggests deficiencies in E2-BCODH activity may hamper the generation of branched chain fatty acids important for S. aureus membrane fluidity and replication. Indeed, supplementation of RPMI medium with BCFA restores growth to the DlipA DlplA1 and DlipA DlplA1 Dlpla2 1 lplA2 strains in vitro, supporting the notion that perturbations in branched chain fatty acid metabolism are at least partially responsible for the growth deficit observed in our study (Supporting Information Fig. S8 ). Our own efforts to generate an e2-BCODH mutant in S. aureus have been unsuccessful suggesting that the activity of this enzyme is critical for bacterial replication (Zorzoli et al., 2016) . This is further supported by the poor growth of a transposon insertion mutant that disrupts BCODH activity (Mashruwala et al., 2016) . The growth of this BCODH null strain is improved by supplementing BCFA to the culture medium. Other experimental perturbations that reduce the demand for lipoic acid-dependent enzyme function -oxygen depletion or mutation of clpC -are likely to yield the same outcome (Mashruwala et al., 2016) . Alternatively, an inability of LplA2 to complement replication defects in vitro may suggest an unappreciated role for the other enzymes in the lplA2-encoding operon for restoration of growth. It is interesting to note that GcvH-L is also encoded in this operon where it is posited to have functions related to redox homeostasis that are regulated by lipoylationdependent ADP-ribosylation by an operon-encoded sirtuin (Rack et al., 2015) . Certainly, a deeper understanding of this locus and its biological activities is warranted and we are currently exploring the relationship between its primary activities and how they relate to lipoic acid salvage. Nonetheless, our data clearly indicate that despite the putative functions of GcvH-L and LplA2 that may be related to redox homeostasis and ADP-ribosylation, GcvH-L can also participate in lipoyl relay to E2 subunits, thereby expanding the functional lipoic acid biosynthesis and salvage pathways of S. aureus. Recent studies from Cao et al. corroborate this notion and provide evidence that many H and H-Like proteins, even those whose activities may not be directly involved in glycine cleavage, have evolved in an unusual way to participate in lipoyl relay (Cao et al., 2018) .
Altogether, this study has expanded our understanding of the lipoic acid salvage strategies of S. aureus and highlights a unique adaptive strategy that is likely to contribute significantly to survival in nutrient deficient environments. Our prior demonstration that LplA1 and LplA2 can compensate for one another during murine infection underscores the biological significance of this point (Zorzoli et al., 2016) . Further, the work herein places this observation within a mechanistic framework by highlighting the divergent targets of these two enzymes and the expanded acquisition pathways imparted by lipoamidase and GcvH-L. Thus, expansion of lipoic acid salvage mechanisms by S. aureus represents a critical adaptive trait likely used for survival in a wide range of nutrient limited environments, including host tissues.
Experimental procedures
Bacterial strains and growth conditions
All bacterial strains used in this manuscript are listed in Table 1 . E. coli strains were routinely grown in Lysogeny Broth (LB) (Amresco) with antibiotics added as necessary. S. aureus strains were grown in either rich medium, Tryptic Soy Broth (TSB) (Criterion), or in defined medium, Roswell Park Memorial Institute medium (RPMI) (Corning) supplemented with 1% casamino acids (Amresco). All strains were grown overnight at 378C at a 458 angle with shaking unless stated otherwise. For growth curves, S. aureus overnight cultures were grown in RPMI containing branched chain carboxylic acids (10 mM isobutyric acid, 9 mM 2-methylbutyric acid, 9 mM isovaleric acid) and 10 mM sodium acetate (Sigma) to bypass the requirement of lipoic acid or octanoic acid for replication (Sigma) (Martin et al., 2009; Martin et al., 2011) . When needed, cultures were supplemented with the following agents for selection: 100 lg ml 21 ampicillin (Amp), 3 lg ml 21 erythromycin (Erm), 10 lg ml 21 chloramphenicol (Cam), 50 lg ml 21 kanamycin (Kan), 50 lg ml 21 neomycin (Neo) and 0.2 mM cadmium chloride.
Molecular genetic techniques
When necessary for validation of mutant strains, chromosomal DNA was isolated from S. aureus using the Wizard Genomic DNA purification kit (Promega) following the manufacturer's protocol with minor modifications. Overnight cultures were started in 5 ml TSB and 1.5 ml was pelleted by centrifugation at 21 000 3 g for 3 min the following day. Bacterial pellets were resuspended in 200 ll of TSM (50 mM Tris, 0.5 M Sucrose, 10 mM MgCl 2 , pH 7.5). To disrupt the cell wall, 2.5 ll of lysostaphin (2 mg ml 21 in 0.5 Tris, pH 8.0) was added to the resuspended cell pellet and incubated for 15 min at 378C. Following incubation, the bacteria were pelleted at 21 000 3 g for 3 min and the supernatant was discarded. The remaining steps to purify genomic DNA from S. aureus were completed using the manufacturer's protocol. Recombinant plasmids were extracted using QIAGEN mini and midi prep kits with the following modifications for plasmid isolation from S. aureus when necessary. An overnight culture of S. aureus was grown in 5 ml TSB and pelleted at 3000 3 g for 10 min the following day. The bacterial pellet was resuspended in 400 ll TSM (50 mM Tris, pH 7.5, 0.5 M Sucrose, 10 mM MgCl 2 ) followed by the addition of 20 ll of lysostaphin. This mixture was incubated for 10 min at 378C to digest the cell wall and then pelleted at 16 000 3 g for 2 min after which the supernatant was discarded. The remaining procedures were completed as suggested by the manufacturer's protocol. Polymerase chain reaction (PCR) products were either gelextracted or purified using QIAGEN QIAquick gel extraction and PCR purification kits. All PCRs were conducted using Phusion high-fidelity DNA polymerase (NEB).
E. coli competent cell preparation
An overnight culture of E. coli was grown in 3 ml LB at 378C with shaking. The next day, the bacteria were subcultured 1:55 into a 250 ml flask and grown for an additional 2.5 h at 378C with shaking until the culture reached an optical density at 600 nm (OD600) of 0.3-0.4. The following steps were all completed on ice. Cultures were aliquoted into 50 ml conical tubes and chilled on ice for 10 min. Afterwards, bacteria were pelleted by centrifugation at 3000 3 g for 10 min and the bacterial pellet was washed twice with 10 ml TFB-1 (20 mM KOAc, 100 mM RbCl 2 , 10 mM CaCl 2 , 50 mM MnCl 2 , 15% glycerol, adjusted to pH 5.8 using 0.2 M Acetic acid) and incubated on ice for 10 min between washes. Bacteria were then pelleted at 3000 3 g for 10 min and resuspended in 1/25 of the original culture volume in TFB-2 (10 mM MOPS, 75 mM CaCl 2 , 10 mM RbCl 2 , 15% glycerol, adjusted to pH 6.5 using KOH). 100 ll of the competent cells were aliquoted into 1.5 ml tubes and stored at 2808C.
E. coli heat transformation
5 ll of ligation mix or 1 ll of purified plasmid were added to 50 ll of competent E. coli. The mixture was incubated on 
AH-LAC with gene replacement of gcvH and in-frame deletion of gcvH-L ice for 30 min, heat shocked at 428C for 45 s, and then incubated for an additional 2 min on ice. 250 ll of super optimal broth with catabolite repression (SOC) medium (0.5% tryptone, 0.5% yeast extract, 0.05% NaCl and 250 mM KCl adjusted to pH 7.0 with 5 M NaOH followed by addition of 20 ml 1M glucose) was added and the bacteria were incubated for 2 h at 378C with shaking. 100 ll of the bacterial suspension was plated onto the appropriate selection medium and incubated overnight at 378C.
Preparation of S. aureus electrocompetent cells
An overnight culture of S. aureus was grown in 5 ml TSB at 378C with shaking. The following day the bacteria were subcultured 1:100 in 30 ml TSB and incubated for an additional 3 h at 378C until the culture reached an OD600 of 0.5. The bacterial culture was pelleted by centrifugation at 3000 3 g for 10 min. All subsequent steps were carried out on ice. After pelleting, the bacteria were washed three times by resuspending in 30 ml ice cold 10% glycerol and pelleted by centrifugation at 3000 3 g for 10 min. After the last wash, the bacteria were suspended in 3 ml 10% glycerol, aliquoted into 1.5 ml tubes, and stored at 2808C.
Transformation of S. aureus
Frozen competent cells were thawed at room temperature for 5 min. 2 ll of plasmid DNA was then added to 50 ll of S. aureus LAC competent cells and incubated at room temperature for 30 min. The competent cell mixture was transferred to sterile 2 mm electroporation cuvettes and pulsed at 1800 V, 10 lF and 600 X. After electroporation, the bacteria were resuspended in 750 ll of TSB or TSB 1 BCFA and incubated at 378C or 308C for 1.5 h. After incubation, the bacteria were pelleted at 10 000 3 g for 2 min and resuspended in 100 ll of TSB or TSB 1 BCFA, plated on TSA or TSA 1 BCFA plates containing antibiotic and incubated at 378C or 308C for 1-2 days.
Generation of a DlipA DlipM DlipL DlplA1 DlplA2 mutant
Strain FA-S1178 (DlipA DlplA1 DlplA2) was used as the recipient strain for transductions with generalized transducing phage /11 harboring marked mutations in lipL (FA-S953 -DlipL::kan) and lipM (NE1334 -lipM::erm). To package /11 with donor DNA, a 3 ml overnight culture of the marked donor strain (FA-S953 or NE1334) was started in TSB 1/-BCFA:LB (1:1) supplemented with 5 mM CaCl 2 and 5 mM MgSO 4 and grown overnight with shaking at 378C. The following day, the overnight strain was subcultured 1:100 into 10 ml TSB 1/-BCFA:LB (1:1) supplemented with 5 mM CaCl 2 and 5 mM MgSO 4 and grown for 2.5-4 h with shaking at 378C until the culture reached an OD600 of 0.3-0.9. 500 ll of the bacterial culture was incubated with 10-fold serial dilutions of /11 phage stock in TMG [10 mM Tris pH 7.5, 5 mM MgCl 2 , 0.01% gelatin (v/v)], vortexed gently and incubated at room temperature for 30 min. After 30 min, tubes containing the bacteria and phage dilutions were mixed with 3 ml CY Top agar (casamino acids 3 g l 21 , yeast extract 3 g l 21 , NaCl 6 g l 21 , 7.5 g l 21 agar, 1/-BCFA as needed) supplemented with 5 mM CaCl 2 and 5 mM MgSO 4 , cooled to 558C, and poured onto TSA 1/-BCFA plates. After the top agar solidified, plates were incubated at 308C overnight face up. The next day the top agar from 2 to 3 plates with confluent plaques was scraped off the plate using a sterile scoopula and resuspended in 2 ml TMG buffer per plate followed by extensive vortexing. The top agar was pelleted by centrifugation at 16 000 3 g for 15 minutes. The supernatant containing /11 phage was filtered twice using a 0.2 lm filter and then an additional two times with a 0.45 lm filter. All phage stocks were stored at 48C.
To transduce marked mutations, the recipient strain FA-S1178 (DlipA DlplA1 DlplA2) was cultured overnight with shaking at 378C in 20 ml TSB 1 BCFA:LB (1:1) supplemented with 5 mM CaCl 2 . The following day, FA-S1178 was pelleted by centrifugation at 16 000 3 g for 15 min and resuspended in 3 ml of TSB 1 BCFA:LB (1:1) supplemented with 5 mM CaCl 2 . 500 ll of the recipient bacteria were serial diluted and incubated with 100 ll of the /11 phage (10 8 -10
9 PFU) collected as described above or 100 ll of TMG buffer as an uninfected control for 30 min at room temperature, inverting the tubes every 10 min. After 30 min the bacteria/phage suspension was supplemented with 40 mM sodium citrate and incubated for an additional 30 min, inverting the tubes every 10 min. The bacteria were pelleted by centrifugation at 16 000 3 g for 3 min and washed twice with 500 ll TSB 1 BCFA:LB (1:1) supplemented with 10 mM sodium citrate. Washed bacterial pellets were resuspended in 250 ll of TSB 1 BCFA:LB (1:1) supplemented with 10 mM sodium citrate and 200 ll was plated on TSA 1 BCFA containing 10 mM sodium citrate supplemented with erythromycin or kanamycin/neomycin as needed. Plates were incubated at 378C for 24-48 h until bacterial colonies were detected. All mutants were verified by PCR.
Generation of DgcvH-L and DgcvH::kan DgcvH-L mutants
Regions of homology corresponding to 498 bp upstream and 492 bp downstream of gcvH-L were amplified using primer pairs gcvH-L-SOE1 and gcvH-L-SOE2 or gcvH-L-SOE3 and gcvH-L-SOE4 (Table 2 ). The amplicons corresponding to the upstream and downstream regions of homology flanking gcvH-L were used as template in a splicing by overlap extension PCR reaction with primers gcvH-L-SOE1 and gcvH-L-SOE4 followed by sub-cloning the resulting amplicon into the allelic replacement plasmid pIMAY to generate pIMAY-gcvH-L (Monk et al., 2012) . pIMAY-gcvH-L was introduced into WT AH-LAC and mutagenesis was carried out as previously described to obtain an in-frame deletion of gcvH-L that removed the entire coding region (Zorzoli et al., 2016) . A marked DgcvH::kan mutation was subsequently transduced into the DgcvH-L strain, as described above, to generate a DgcvH::kan DgcvH-L double mutant.
Generation of DgcvH::kan 1 gcvH, DgcvH::kan 1 gcvH-L, DgcvH-L 1 gcvh-L, DgcvH::kan DgcvH-L 1 gcvH and DgcvH::kan DgcvH-L 1 gcvH-L strains DgcvH::kan 1 gcvH, DgcvH::kan 1 gcvH-L, DgcvH-L 1 gcvh-L, DgcvH::kan DgcvH-L 1 gcvH and DgcvH::kan DgcvH-L 1 gcvH-L complementation strains were generated using plasmid pJC1111, which stably integrates into the SaPI-1 site of the S. aureus chromosome after passage through S. aureus strain RN9011 containing pRN7203 expressing the SaPI-1 integrase, leading to single-copy stable integration of the plasmid (Chen et al., 2014) . We first generated pJC1111 plasmids that drive expression of the gcvH or gcvH-L genes under the control of the constitutive P HELP promoter obtained from allelic replacement plasmid pIMAY (Riedel et al., 2007; Monk et al., 2008; Monk et al., 2012) . The oligonucleotides listed in Table 2 were used to amplify the P HELP promoter and the open reading frames corresponding to gcvH and gcvH-L including 150 nucleotides downstream of the stop codon. The P HELP amplicon was combined with either the gcvH or gcvH-L amplicon and the two fragments were joined by splicing by overlap extension PCR. The resulting P HELP -gcvH and P HELP -gcvH-L amplicons were subsequently purified and cloned into pJC1111 after digestion with restriction endonucleases PstI and SacI and subsequent ligation into similarly digested pJC1111, generating pJC1111-P HELP -gcvH and pJC1111-P HELPgcvH-L.
Both pJC1111-P HELP -gcvH and pJC1111-P HELP -gcvH-L were propagated in E. coli DC10B, followed by isolation and subsequent electroporation into S. aureus RN9011 and plating on TSA plates supplemented with chloramphenicol and CdCl 2. Plasmid integrants were used as donors to package and transduce the complementation allele into the AH-LAC DgcvH::kan, DgcvH-L and DgcvH::kan DgcvH-L strain backgrounds. Final complementation strains were selected based on their CdCl 2 resistance and validated via PCR. This resulted in the generation of the strains designated DgcvH::kan 1 gcvH, DgcvH::kan 1 gcvH-L, DgcvH-L 1 gcvh-L, DgcvH::kan DgcvH-L 1 gcvH and DgcvH::kan DgcvH-L 1 gcvH-L.
used to generate P HELP -gcvH-L (Table 2) to validate the substitution (K56A). The resultant pJC1111-P HELP -gcvH-L* was introduced into the DgcvH::kan strain as described above, yielding DgcvH::kan 1 gcvH-L* Whole cell lysate preparation Wild type and mutant S. aureus strains were grown overnight at 378C with shaking in 15 ml conical tubes containing 5 ml of RPMI 1 BCFA medium. 50 ll of these overnight cultures was inoculated into 15 ml conical tubes containing 5 ml of RPMI 1 BCFA; RPMI 1 BCFA 1 5 lM a-lipoic acid, or RPMI 1 BCFA 1 150 lM octanoic acid. Samples were incubated with shaking at 200 rpm for 9 h and bacterial growth was determined by measuring OD600 using a Genesys 10S UV-Vis spectrophotometer (Thermo Scientific). The remaining culture volume was centrifuged at 3000 3 g for 15 min, the supernatant was discarded, and the bacterial pellets were suspended in 250 ll of PBS and transferred to screw cap microcentrifuge lysing tubes (Fisher Scientific) containing 250 ll of 0.1 mm glass cell disruption beads (Scientific Industries). Cells were lysed using a Fast Prep-24 5G (MP Biomedicals) bead disruption system in two sequential steps, at 5.0 speed for 20 s and at 4.5 speed for 20 s, each separated by a 5 min incubation period on ice. After cell disruption, samples were centrifuged at 19 000 3 g for 15 min. 45 ll of the supernatant were collected in microcentrifuge tubes containing 15 ll of 6X SDS sample buffer and subsequently boiled for 10 min prior to storage at 2208C.
Determination of protein lipoylation and LplA2 levels in whole cell lysates
Protein samples from OD-normalized whole cell lysates were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) in 12% polyacrylamide gels at 120 volts for approximately 4 h. Gel staining was performed to evaluate protein patterns and equivalent loading of samples using GelCode Blue stain reagent (Thermo Scientific) with PageRuler Prestained Protein Ladder (Thermo Scientific) used as a molecular weight marker. Protein lipoylation and LplA2 levels were assessed via immunoblot. Briefly, resolved proteins were transferred from polyacrylamide gels to 0.2 lm PVDF membranes (Immobilon, Roche) at 70 V for 1 h and 15 min in a Trans-BlotV R Cell (Bio-Rad). After transfer, membranes were incubated for 1 h with TBST (0.1% Tween-20 in Tris Buffered Saline) supplemented with 5% bovine serum albumin (BSA) at room temperature. A 1:3000 dilution of rabbit polyclonal alipoic acid antibody (Calbiochem) or 1:50 000 dilution of rabbit polyclonal a-LplA2 antibody (Pacific Immunology) was added to the membrane followed by incubation for 1 h and three subsequent washes in 20 ml of TBST. APconjugated Goat anti-Rabbit IgG (H 1 L) (Invitrogen) was then added at a 1:5000 dilution in TBST for 45 min followed by three 15 minute washes in 20 ml of TBST. Membranes were developed with BCIP/NBT (5-bromo-4-chloro-3-indoyl-phosphate/nitro blue tetrazolium) color development substrate (VWR).
Preparation of Proteinase K agarose beads and digestion of porcine PDH Proteinase K agarose beads and porcine pyruvate dehydrogenase (PDH) were purchased from Sigma. The Proteinase K beads were activated by suspending 40 mg beads in 1 ml activation buffer (20 mM Tris-HCl, 1 mM CaCl 2, pH 7.4) and incubated for 2 h at room temperature. Before protein digestion, the beads were washed three times by centrifugation for 3 min at 400 3 g followed by resuspension in 800 ll activation buffer. PDH (16.0 mg ml 21 ) was exchanged from its storage buffer into 20 mM Tris-HCl, 1 mM CaCl 2 pH 7.4. Briefly, 2 ml PDH solution was diluted into 18 ml of 20 mM Tris-HCl, 1 mM CaCl 2 pH 7.4 followed by concentration to 250 ll using a 10 kDa cut-off Amicon Ultra-15 spin column (Milipore). This step was repeated 5 times. After buffer exchange, 2.5 mg ml 21 PDH was digested overnight with 400 ll Proteinase K agarose bead suspension. The following morning, the beads were removed from the digestion reaction by centrifugation at 16 000 3 g for 10 min and the supernatant was used in subsequent growth curves.
Growth curves
Overnight cultures were grown in 200 ll of RPMI 1 BCFA in a 96-well plate at 378C with shaking. The next day, the strains were pelleted for 10 min at 2000 3 g at 48C. The strains were washed three to five times with 200 ll of RPMI to remove any remaining BCFA that might stimulate growth. Each strain was grown in RPMI supplemented with 5 lM lipoic acid (Sigma), 25 lM octanoic acid (Sigma), 0.25 mg ml 21 PDH (Sigma) or the volume equivalent of proteinase K digested PDH, and 100 lM DK L A or 100 lM DKA tripeptides (Anaspec). All growth curves were conducted in a 96-well plate at 378C for 8-10 h until reaching stationary phase. Changes in turbidity were recorded every hour by measuring OD550 on a BioTek plate reader.
Generation of 6x-Histidine tagged protein expression plasmids
The coding sequences of lplA1, lplA2 e2-PDH, e2-OGDH, e2-BCODH, gcvH and gcvH-L, were amplified using the following primer pairs: His-LplA1-F/His-LplA1-R (lplA1), HisLplA2-F/His-LplA2-R (lplA2), His-E2PDH-F/His-E2PDH-R (e2-PDH), His-E2OGDH-F/His-E2OGDH-R (e2-OGDH), His-E2BCODH-F/His-E2BCODH-R (e2-BCODH), HisGcvH-F/His-GcvH-R (gcvH) and His-GcvH-L-F/His-GcvH-L-R (gcvH-L) (See Table 2 ). The resulting amplicons were sub-cloned into protein expression vector pET-15b using NdeI and BamHI restriction endonucleases to generate expression plasmids containing each gene with an Nterminal 6x-Histidine tag. Plasmids containing 6x-His-lplA1 and 6x-His-lplA2 were transformed into lysY/I q E. coli and plasmids containing 6x-His-e2-PDH, 6x-His-e2-OGDH, 6x-His-e2-BCODH, 6x-His-gcvH and 6x-His-gcvH-L were transformed into DlipA::kan lysY/I q E. coli to ensure each subunit would be purified in its apo form (Grayczyk et al., 2017) .
Purification of LplA1 and LplA2
LplA1 and LplA2 were purified using Ni 21 affinity chromatography. lysY/I q E. coli strains containing pET15b-6x-HislplA1, and pET15b-6x-His-lplA1 were grown in 5 ml LB with 100 lg ml 21 ampicillin at 378C with shaking overnight. The following day, bacteria were subcultured 1:100 and allowed to grow for 3 hours at 378C until reaching an OD600 of 0.25-0.3. Protein expression was induced on addition of 0.1 mM IPTG followed by incubation for 16 h at 168C with shaking. The next day, bacteria were pelleted by centrifugation at 13 000 3 g for 10 min at 48C followed by storage at 2808C. To purify the recombinant proteins, bacterial pellets were thawed at 378C and resuspended in lysis buffer (25 mM imidazole, 50 mM Tris-HCl, 300 mM NaCl, pH 8) supplemented with 1 mM dithiothreitol (DTT) and 1 mM phenylmethylsulfonyl fluoride (PMSF). The bacteria were lysed at a constant rate of 0.8 s per pulse and an output of 340 W in 20 s intervals for 15 min on ice using a Branson S-450A large tip sonicator. Debris from lysed bacteria was pelleted by centrifugation for 30 min at 16 000 3 g followed by filtration of the clarified lysate using a 0.45 lm syringe filter. The lysate was then incubated with 1 ml nickel-NTA resin (Qiagen) while rocking for 1 h at 48C, washed with wash buffer (50 mM imidazole, 1 mM DTT, 50 mM Tris-HCl, 300 mM NaCl, pH 8.0), followed by elution of the bound protein using the same buffer containing 500 mM imidazole. Samples were dialyzed with 10 kDa molecular weight cutoff (MWCO) snakeskin dialysis tubing (Thermo Scientific) using the following scheme: the sample was first placed into 1 l buffer containing 100 mM imidazole, 50 mM TrisHCl, 300 mM NaCl, pH 8 for 3 h, then into buffer containing 25 mM imidazole, 50 mM Tris-HCl, 300 mM NaCl, pH 8 overnight, followed by an additional 4 h in buffer containing 50 mM Tris-HCl, 300 mM NaCl, pH 8 the following day. The concentration of the purified protein was measured using a bicinchoninic acid (BCA) kit (Thermo Scientific) and stored at 2808C. Protein purity was confirmed by resolving 2 lg of purified protein on SDS-PAGE gels followed by staining with GelCode Blue. Where necessary, proteins were further purified to homogeneity using fast protein liquid chromatography (FPLC) on a Superdex 100 Increase 3.2/300 size exclusion column.
Purification of E2 and H subunits of lipoylated enzyme complexes
The E2-subunits of PDH, BCODH, OGDH, GcvH and GcvH-L were purified from a DlipA::kan lysY/I q E. coli strain using Ni 21 affinity chromatography. DlipA::kan lysY/I q E. coli strains containing pET15b-6x-His-e2-PDH, and pET15b-6x-His-E2-OGDH, pET15b-6x-His-e2-BCODH, pET15b-6x-HisgcvH and pET15b-6x-His-gcvH-L were grown overnight in 30 ml LB with 100 lg ml 21 ampicillin at 378C with shaking. The following day, strains were subcultured 1:100 into LB medium containing 100 lg ml 21 ampicillin and grown for 20 h at 378C with shaking. The next day, protein expression was induced with 0.5 mM IPTG for 4 h at 378C with shaking. After induction, the bacteria were pelleted by centrifugation at 13 000 3 g for 10 min at 48C and stored at 2808C overnight. The remaining purification of E2 and H subunits followed the same protocol used for LplA1 and LplA2 described above.
Lipoylation and octanoylation assays
Lipoylation assays were set up as described by Martin et al with some modifications (Martin et al., 2011) . All assays were conducted in 50 ll reaction volumes in reaction buffer (50 mM Tris-HCl, 300 mM NaCl, pH 8.0) containing 6 mM ATP, 1 mM DTT, 1 mM MgCl 2 , 1 lM purified LplA1 or LplA2, and 20 lM substrate (E2-PDH, E2-OGDH, E2-BCODH, GcvH, or GcvH-L). The reactions were incubated with or without lipoic acid (2.4 mM), octanoic acid (2.4 mM), or DK L A (2.4 mM) for 2 h at 378C with shaking. After incubation, the reaction mixtures were resolved on parallel 12% SDS-PAGE gels at 120 V for approximately 3 h. One gel was stained with GelCode Blue (Thermo Scientific) and the other was used for immunoblotting. The resolved reactions were transferred to 0.2 lM PVDF membranes at 1000 mA for 1 h. After transfer, the membrane was blocked overnight at 48C in Tris-buffered saline 1 0.1% Tween (TBST) containing 5% bovine serum albumin (BSA). The following day, rabbit a-lipoic acid antibody was added to the membrane at a dilution of 1:7500 in TBST 1 5% BSA for 1 h at room temperature with rocking. The membrane was washed three times in TBST followed by addition of goat a-rabbit IgG AP conjugate to the membrane at a 1:5000 dilution in TBST 1 5% BSA for 1 h at room temperature. The membrane was washed three times in TBST at 15 min intervals followed by visualization of lipoylated proteins using colorimetric detection on addition of 66 ll of nitro-blue tetrazolium (NBT) (50 mg NBT in 1 ml 70% dimethylformamide (DMF)/30% H 2 O) and 35 ll of 5-bromo-4-chloro-3'-indolyphosphate (BCIP) (50 mg BCIP in 1 ml DMF) to 10 ml AP Buffer (100 mM Tris, 100 mM NaCl, 5 mM MgCl 2, pH 9.5) and incubating the membrane with this solution for 2 min while rocking at room temperature. Development of the blot was stopped by washing the membrane with water and allowing it to dry at 378C for 15 min.
Lipoamidase activity assay
Overnight cultures of the DlipA DlipM DlipL DlplA1 DlplA2 S. aureus strain lacking all enzymes involved in de novo biosynthesis and salvage of lipoic acid was grown in 5 ml RPMI 1 BCFA at 378C with shaking. The following day, the strain was subcultured 1:100 in 6 ml of RPMI 1 BCFA and grown for 9 h at 378C with shaking. The bacteria were pelleted by centrifugation at 3000 3 g for 15 min, the supernatant discarded and remaining pellet stored at 2808C. The following day, the bacterial pellet was thawed on ice for 10 min, resuspended in 250 ll 1X PBS and transferred to microcentrifuge screw-cap tubes containing 250 ll 0.1 mm glass cell disruption beads (Scientific Industries). The bacteria were lysed using a Fast Prep-24 5G (MP Biomedicals) at speed 5.0 for 20 s followed by speed 4.5 for an additional 20 s with 5 min incubation on ice between lysis steps. After lysis, the samples were centrifuged at 18 000 3 g for 15 min and clarified lysates were collected Lipoic acid salvage in S. aureus 165 and immediately used in subsequent assays of amidotransferase activity.
Amidotransferase activity was assayed in 50 ll reaction volumes containing 6 mM ATP, 1 mM DTT, 1 mM MgCl 2 , 1 lM purified LplA1 or LplA2, 20 lM substrate (GcvH or GcvH-L) and 35 ll of DlipA DlipM DlipL DlplA1 DlplA2 mutant whole cell lysates, prepared as described above. The reactions were incubated with or without DK L A (2.4 mM) for 2 hours at 378C with shaking. After incubation, proteins were resolved on parallel SDS-PAGE gels for staining with GelCode Blue (Thermo Scientific) and immunoblot with rabbit a-lipoic acid antibody as described above.
Reproducibility and experimental rigor
All growth curves were conducted three times in triplicate. Data shown are of a single representative growth curve conducted in triplicate with error bars reflecting the standard deviation between samples. When no error bars are shown, this reflects a data point where the error was smaller than the size of the symbol used to plot that point. All biochemical assays were conducted at least four times with two independent preparations of recombinant proteins to ensure reproducibility and rule out effects of any potential impurities. DKA, DK L A, DKT and DK L T tri-peptides were synthesized by Anaspec and purified by HPLC.
